Makoto Fujino, Masahiro Kawashima, Hajime Yoshifuji, Ran Nakashima, Yosuke Yamada, Yoshiaki Matsumoto, Nobuko Kawaguchi-Sakita, Yukiko Mori, Fengling Pu, Ayane Yamaguchi, et al. Remarkable remission of symptomatic dermatomyositis after curative breast cancer surgery. International Cancer Conference Journal. 2024
Ayane Yamaguchi, Kosuke Kawaguchi, Kana Kawanishi, Yurina Maeshima, Akiyoshi Nakakura, Tatsuki R Kataoka, Sachiko Takahara, Shunsaku Nakagawa, Atsushi Yonezawa, Masahiro Takada, et al. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis. Breast cancer research and treatment. 2023
Masako Kataoka, Maya Honda, Hajime Sagawa, Akane Ohashi, Rena Sakaguchi, Hina Hashimoto, Mami Iima, Masahiro Takada, Yuji Nakamoto. Ultrafast Dynamic Contrast-Enhanced MRI of the Breast: From Theory to Practice. Journal of magnetic resonance imaging : JMRI. 2023
Masahiro Takada, Shigeru Imoto, Takanori Ishida, Yoshinori Ito, Hiroji Iwata, Norikazu Masuda, Hirofumi Mukai, Shigehira Saji, Takafumi Ikeda, Hironori Haga, et al. A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer. Breast cancer research and treatment. 2023. 202. 3. 485-496
Mitsuo Terada, Aki Ito, Yuichiro Kikawa, Kei Koizumi, Yoichi Naito, Tatsunori Shimoi, Mikiya Ishihara, Takashi Yamanaka, Yukinori Ozaki, Fumikata Hara, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition. Breast cancer (Tokyo, Japan). 2023. 30. 6. 872-884
Kosuke Kawaguchi, Masahiro Takada, Takeshi Kotake, Michio Yoshimura, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Reitaro Tokumasu, Hironori Kato, Hiroshi Yoshibayashi, et al. Predicting the efficacy of nivolumab combined with radiation therapy by longitudinal liquid biopsy with artificial intelligence for patients with metastatic breast cancer (translational research of the KBCRN-B-002 trial). JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
Ayane Yamaguchi, Kosuke Kawaguchi, Hiroshi Ishiguro, Tatsuki R. Kataoka, Masae Torii, Chenfeng He, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Masahiro Takada, Eiji Suzuki, et al. The long-lasting anti-tumor activity of cisplatin affecting the sustainable systemic immune alteration may improve distant-disease free survival of triple-negative breast cancer in patients with a substantial residual tumor following preoperative chemotherapy: A retrospective analysis with translational research. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
Treatment for HER2-positive MBC
(Best of San Antonio Breast Cancer Symposium Kyoto 2021)
Prediction tools to identify high-risk individuals
(Kyoto Breast Cancer Consensus Conference 2021 2021)
Absolute Benefit of S-1 Postoperative Therapy for ER-positive, HER2-negative Breast Cancer: Exploratory Analysis of the phase 3 POTENT trial
(ASCO Annual Meeting 2020)
Oligometastatic Breast Cancer -Role of Locoregional Methods
(III EAFO Breast Cancer Forum 2020)
